{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T13:57:37Z","timestamp":1760623057330,"version":"3.37.3"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R01 HL31814-01A1"],"award-info":[{"award-number":["R01 HL31814-01A1"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006519","name":"Edna and Fred L. Mandel, Jr. Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006519","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular Signalling"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.cellsig.2018.02.013","type":"journal-article","created":{"date-parts":[[2018,2,27]],"date-time":"2018-02-27T23:12:12Z","timestamp":1519773132000},"page":"113-119","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Understanding the mechanism of bias signaling of the insulin-like growth factor 1 receptor: Effects of LL37 and HASF"],"prefix":"10.1016","volume":"46","author":[{"given":"Akshay","family":"Bareja","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shubham","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Conrad P.","family":"Hodgkinson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan","family":"Payne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victor J.","family":"Dzau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.cellsig.2018.02.013_bb0005","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1136\/mp.54.3.149","article-title":"Insulin-like growth factor 1 and oestradiol promote cell proliferation of MCF-7 breast cancer cells: new insights into their synergistic effects","volume":"54","author":"Dupont","year":"2001","journal-title":"Mol. Pathol."},{"issue":"15","key":"10.1016\/j.cellsig.2018.02.013_bb0010","doi-asserted-by":"crossref","first-page":"R657","DOI":"10.1016\/j.cub.2009.06.013","article-title":"Converging pathways in lifespan regulation","volume":"19","author":"Narasimhan","year":"2009","journal-title":"Curr. Biol."},{"issue":"1","key":"10.1016\/j.cellsig.2018.02.013_bb0015","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/2044-5040-1-4","article-title":"Regulation of skeletal muscle growth by the IGF1-Akt\/PKB pathway: insights from genetic models","volume":"1","author":"Schiaffino","year":"2011","journal-title":"Skelet. Muscle"},{"issue":"6","key":"10.1016\/j.cellsig.2018.02.013_bb0020","doi-asserted-by":"crossref","first-page":"4782","DOI":"10.1074\/jbc.M310405200","article-title":"The insulin-like growth factor 1 receptor induces physiological heart growth via the phosphoinositide 3-kinase(p110alpha) pathway","volume":"279","author":"McMullen","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"21","key":"10.1016\/j.cellsig.2018.02.013_bb0025","first-page":"4624","article-title":"IGF-1\/GH axis enhances losartan treatment in Lama2-related muscular dystrophy","volume":"25","author":"Accorsi","year":"2016","journal-title":"Human Mol. Genet."},{"issue":"2","key":"10.1016\/j.cellsig.2018.02.013_bb0030","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s13539-011-0029-3","article-title":"IGF-1 treatment reduces weight loss and improves outcome in a rat model of cancer cachexia","volume":"2","author":"Schmidt","year":"2011","journal-title":"J. Cachexia. Sarcopenia Muscle"},{"issue":"11","key":"10.1016\/j.cellsig.2018.02.013_bb0035","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1210\/me.2015-1157","article-title":"Minireview: were the IGF signaling inhibitors all bad?","volume":"29","author":"Beckwith","year":"2015","journal-title":"Mol. Endocrinol."},{"issue":"2","key":"10.1016\/j.cellsig.2018.02.013_bb0040","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1172\/JCI117706","article-title":"Insulin-like growth factor-1 enhances ventricular hypertrophy and function during the onset of experimental cardiac failure","volume":"95","author":"Duerr","year":"1995","journal-title":"J. Clin. Invest."},{"issue":"3","key":"10.1016\/j.cellsig.2018.02.013_bb0045","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/nrd3954","article-title":"Signalling bias in new drug discovery: detection, quantification and therapeutic impact","volume":"12","author":"Kenakin","year":"2013","journal-title":"Nat. Rev. Drug Discov."},{"issue":"3","key":"10.1016\/j.cellsig.2018.02.013_bb0050","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/FJC.0000000000000356","article-title":"G protein-coupled receptor biased agonism","volume":"67","author":"Hodavance","year":"2016","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.cellsig.2018.02.013_bb0055","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1146\/annurev.pharmtox.010909.105800","article-title":"Molecular mechanism of beta-arrestin-biased agonism at seven-transmembrane receptors","volume":"52","author":"Reiter","year":"2012","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"issue":"3","key":"10.1016\/j.cellsig.2018.02.013_bb0060","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/onc.2011.239","article-title":"Identification of the cathelicidin peptide LL-37 as agonist for the type I insulin-like growth factor receptor","volume":"31","author":"Girnita","year":"2012","journal-title":"Oncogene"},{"issue":"8","key":"10.1016\/j.cellsig.2018.02.013_bb0065","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1002\/stem.1416","article-title":"Abi3bp is a multifunctional autocrine\/paracrine factor that regulates mesenchymal stem cell biology","volume":"31","author":"Hodgkinson","year":"2013","journal-title":"Stem Cells"},{"issue":"3","key":"10.1016\/j.cellsig.2018.02.013_bb0070","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S1535-6108(04)00051-0","article-title":"In vivo antitumor activity of NVP-AEW541-a novel, potent, and selective inhibitor of the IGF-IR kinase","volume":"5","author":"Garcia-Echeverria","year":"2004","journal-title":"Cancer Cell"},{"issue":"51","key":"10.1016\/j.cellsig.2018.02.013_bb0075","doi-asserted-by":"crossref","first-page":"51334","DOI":"10.1074\/jbc.M309968200","article-title":"Beta-arrestin1 mediates insulin-like growth factor 1 (IGF-1) activation of phosphatidylinositol 3-kinase (PI3K) and anti-apoptosis","volume":"278","author":"Povsic","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cellsig.2018.02.013_bb0080","doi-asserted-by":"crossref","first-page":"106","DOI":"10.3389\/fendo.2015.00106","article-title":"IGF-1 receptor and adhesion signaling: an important Axis in determining cancer cell phenotype and therapy resistance","volume":"6","author":"Cox","year":"2015","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"4","key":"10.1016\/j.cellsig.2018.02.013_bb0085","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/nm0405-367","article-title":"Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells","volume":"11","author":"Gnecchi","year":"2005","journal-title":"Nat. Med."},{"issue":"11","key":"10.1016\/j.cellsig.2018.02.013_bb0090","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1161\/CIRCRESAHA.108.176826","article-title":"Paracrine mechanisms in adult stem cell signaling and therapy","volume":"103","author":"Gnecchi","year":"2008","journal-title":"Circ. Res."},{"issue":"4","key":"10.1016\/j.cellsig.2018.02.013_bb0095","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1161\/CIRCRESAHA.113.301075","article-title":"C3orf58, a novel paracrine protein, stimulates cardiomyocyte cell-cycle progression through the PI3K-AKT-CDK7 pathway","volume":"113","author":"Beigi","year":"2013","journal-title":"Circ. Res."},{"key":"10.1016\/j.cellsig.2018.02.013_bb0100","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.yjmcc.2013.11.010","article-title":"HASF is a stem cell paracrine factor that activates PKC epsilon mediated cytoprotection","volume":"66","author":"Huang","year":"2014","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"5","key":"10.1016\/j.cellsig.2018.02.013_bb0105","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1042\/BCJ20160976","article-title":"HASF (C3orf58) is a novel ligand of the insulin-like growth factor 1 receptor","volume":"474","author":"Bareja","year":"2017","journal-title":"Biochem. J."},{"issue":"1","key":"10.1016\/j.cellsig.2018.02.013_bb0110","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1161\/CIRCRESAHA.115.305373","article-title":"Emerging concepts in paracrine mechanisms in regenerative cardiovascular medicine and biology","volume":"118","author":"Hodgkinson","year":"2016","journal-title":"Circ. Res."},{"issue":"7596","key":"10.1016\/j.cellsig.2018.02.013_bb0115","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/nature17198","article-title":"Beta-Arrestin biosensors reveal a rapid, receptor-dependent activation\/deactivation cycle","volume":"531","author":"Nuber","year":"2016","journal-title":"Nature"},{"issue":"18","key":"10.1016\/j.cellsig.2018.02.013_bb0120","doi-asserted-by":"crossref","first-page":"7055","DOI":"10.1073\/pnas.1118359109","article-title":"Selective recruitment of G protein-coupled receptor kinases (GRKs) controls signaling of the insulin-like growth factor 1 receptor","volume":"109","author":"Zheng","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2","key":"10.1016\/j.cellsig.2018.02.013_bb0125","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1161\/CIRCRESAHA.115.308238","article-title":"DUSP8 regulates cardiac ventricular remodeling by altering ERK1\/2 signaling","volume":"119","author":"Liu","year":"2016","journal-title":"Circ. Res."},{"issue":"3","key":"10.1016\/j.cellsig.2018.02.013_bb0130","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1046\/j.1523-1747.2003.12069.x","article-title":"The cathelicidin anti-microbial peptide LL-37 is involved in re-epithelialization of human skin wounds and is lacking in chronic ulcer epithelium","volume":"120","author":"Heilborn","year":"2003","journal-title":"J. Invest. Dermatol."},{"issue":"11","key":"10.1016\/j.cellsig.2018.02.013_bb0135","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1172\/JCI17545","article-title":"An angiogenic role for the human peptide antibiotic LL-37\/hCAP-18","volume":"111","author":"Koczulla","year":"2003","journal-title":"J. Clin. Invest."},{"issue":"3","key":"10.1016\/j.cellsig.2018.02.013_bb0140","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1189\/jlb.1005560","article-title":"The human cationic host defense peptide LL-37 mediates contrasting effects on apoptotic pathways in different primary cells of the innate immune system","volume":"80","author":"Barlow","year":"2006","journal-title":"J. Leukoc. Biol."},{"issue":"4","key":"10.1016\/j.cellsig.2018.02.013_bb0145","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1038\/jid.2008.321","article-title":"The human antimicrobial peptide LL-37 suppresses apoptosis in keratinocytes","volume":"129","author":"Chamorro","year":"2009","journal-title":"J. Invest. Dermatol."}],"container-title":["Cellular Signalling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656818300603?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656818300603?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,9]],"date-time":"2019-08-09T01:40:15Z","timestamp":1565314815000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0898656818300603"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":29,"alternative-id":["S0898656818300603"],"URL":"https:\/\/doi.org\/10.1016\/j.cellsig.2018.02.013","relation":{},"ISSN":["0898-6568"],"issn-type":[{"type":"print","value":"0898-6568"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Understanding the mechanism of bias signaling of the insulin-like growth factor 1 receptor: Effects of LL37 and HASF","name":"articletitle","label":"Article Title"},{"value":"Cellular Signalling","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cellsig.2018.02.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}